GERRESHEIMER AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.5 EUR | +1.31% |
|
+1.62% | +6.52% |
| 22/04 | GERRESHEIMER AG : Buy rating from Barclays | ZD |
| 22/04 | GERRESHEIMER AG : Jefferies remains its Buy rating | ZD |
| Sales 2024 * | 2.13B 2.28B 190B | Sales 2025 * | 2.39B 2.55B 213B | Capitalization | 3.47B 3.71B 310B |
|---|---|---|---|---|---|
| Net income 2024 * | 142M 152M 12.66B | Net income 2025 * | 194M 207M 17.3B | EV / Sales 2024 * | 2.09 x |
| Net Debt 2024 * | 992M 1.06B 88.47B | Net Debt 2025 * | 968M 1.03B 86.32B | EV / Sales 2025 * | 1.86 x |
| P/E ratio 2024 * |
24.3
x | P/E ratio 2025 * |
17.7
x | Employees | 11,947 |
| Yield 2024 * |
1.33% | Yield 2025 * |
1.63% | Free-Float | 100% |
More Fundamentals
* Assessed data
More news
Latest transcript on Gerresheimer AG
More press releases
| 1 day | +1.31% | ||
| 1 week | +1.62% | ||
| Current month | -3.74% | ||
| 1 month | +0.50% | ||
| 3 months | +5.29% | ||
| 6 months | +15.12% | ||
| Current year | +6.52% |
1 week
99.05
103.40
1 month
96.15109.00
Current year
84.80111.20
1 year
81.35122.90
3 years
46.66122.90
5 years
46.66122.90
10 years
41.04122.90
| Managers | Title | Age | Since |
|---|---|---|---|
Dietmar Siemssen
CEO | Chief Executive Officer | 60 | 01/18/01 |
Bernd Metzner
DFI | Director of Finance/CFO | 53 | 15/19/15 |
Guido Pickert
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Axel Herberg
CHM | Chairman | 66 | 01/14/01 |
| Director/Board Member | 67 | 26/12/26 | |
| Director/Board Member | 69 | 01/07/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.62% | 17 M€ | -.--% | - | |
| 2.97% | 202 M€ | -.--% | ||
| 0.25% | 18 M€ | +7.68% | ||
| 0.23% | 79 M€ | -.--% | ||
| 0.07% | 773 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 100.5 | +1.31% | 55,957 |
| 25/24/25 | 99.2 | -2.17% | 95,926 |
| 24/24/24 | 101.4 | -0.59% | 93,149 |
| 23/24/23 | 102 | +0.69% | 61,420 |
| 22/24/22 | 101.3 | +2.43% | 83,502 |
Delayed Quote Xetra, April 26, 2024 at 09:11 pm IST
More quotes
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Calendar
05/05/2024
- RDD Europe Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
100.5
EUR
Average target price
132.9
EUR
Spread / Average Target
+32.23%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.52% | 3.71B | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.36% | 26.25B | |
| +2.07% | 26.48B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- GXI Stock
